Cost-Effectiveness Analysis of Evolocumab Therapy in Patients at High Risk of Cardiovascular Events in the Context of the Brazilian Unified Health System.
Luiza LatadoRodrigo Morel Vieira de MeloSostenes MistroAdriana Lopes Latado BragaHarrison Floriano do NascimentoYasmin Menezes LiraNatalia Ferreira Cardoso de OliveiraYuri de Santana GalindoTainá Teixeira VianaLuiz Carlos Santana PassosPublished in: Arquivos brasileiros de cardiologia (2021)
LASRr and LASRct were the best discriminators for LVH secondary to HCM. LASRcd predicted the degree of LV fibrosis assessed by CMR. These findings suggest that LA mechanics is a potential predictor of disease severity in HCM.